Cargando…
537 STaR: Single-Tablet Regimen Rilpivirine/Emtricitabine/Tenofovir DF has Similar Efficacy and is Well-Tolerated Compared to Efavirenz/Emtricitabine/Tenofovir DF in ART-Naïve Females at Week 96
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5782352/ http://dx.doi.org/10.1093/ofid/ofu051.56 |
| _version_ | 1783295174273662976 |
|---|---|
| author | Creticos, Catherine Brinson, Cynthia Mcdonald, Cheryl Segal-Maurer, Sorana Brar, Indira Wade, Barbara Garner, Will Porter, Danielle De-Oertel, Shampa Weinberg, Amy Sparrow, Toni |
| author_facet | Creticos, Catherine Brinson, Cynthia Mcdonald, Cheryl Segal-Maurer, Sorana Brar, Indira Wade, Barbara Garner, Will Porter, Danielle De-Oertel, Shampa Weinberg, Amy Sparrow, Toni |
| author_sort | Creticos, Catherine |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5782352 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2014 |
| publisher | Oxford University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-57823522018-03-01 537 STaR: Single-Tablet Regimen Rilpivirine/Emtricitabine/Tenofovir DF has Similar Efficacy and is Well-Tolerated Compared to Efavirenz/Emtricitabine/Tenofovir DF in ART-Naïve Females at Week 96 Creticos, Catherine Brinson, Cynthia Mcdonald, Cheryl Segal-Maurer, Sorana Brar, Indira Wade, Barbara Garner, Will Porter, Danielle De-Oertel, Shampa Weinberg, Amy Sparrow, Toni Open Forum Infect Dis IDWeek 2014 Abstracts Oxford University Press 2014-12 2014-12 /pmc/articles/PMC5782352/ http://dx.doi.org/10.1093/ofid/ofu051.56 Text en © The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America |
| spellingShingle | IDWeek 2014 Abstracts Creticos, Catherine Brinson, Cynthia Mcdonald, Cheryl Segal-Maurer, Sorana Brar, Indira Wade, Barbara Garner, Will Porter, Danielle De-Oertel, Shampa Weinberg, Amy Sparrow, Toni 537 STaR: Single-Tablet Regimen Rilpivirine/Emtricitabine/Tenofovir DF has Similar Efficacy and is Well-Tolerated Compared to Efavirenz/Emtricitabine/Tenofovir DF in ART-Naïve Females at Week 96 |
| title | 537 STaR: Single-Tablet Regimen Rilpivirine/Emtricitabine/Tenofovir DF has Similar Efficacy and is Well-Tolerated Compared to Efavirenz/Emtricitabine/Tenofovir DF in ART-Naïve Females at Week 96 |
| title_full | 537 STaR: Single-Tablet Regimen Rilpivirine/Emtricitabine/Tenofovir DF has Similar Efficacy and is Well-Tolerated Compared to Efavirenz/Emtricitabine/Tenofovir DF in ART-Naïve Females at Week 96 |
| title_fullStr | 537 STaR: Single-Tablet Regimen Rilpivirine/Emtricitabine/Tenofovir DF has Similar Efficacy and is Well-Tolerated Compared to Efavirenz/Emtricitabine/Tenofovir DF in ART-Naïve Females at Week 96 |
| title_full_unstemmed | 537 STaR: Single-Tablet Regimen Rilpivirine/Emtricitabine/Tenofovir DF has Similar Efficacy and is Well-Tolerated Compared to Efavirenz/Emtricitabine/Tenofovir DF in ART-Naïve Females at Week 96 |
| title_short | 537 STaR: Single-Tablet Regimen Rilpivirine/Emtricitabine/Tenofovir DF has Similar Efficacy and is Well-Tolerated Compared to Efavirenz/Emtricitabine/Tenofovir DF in ART-Naïve Females at Week 96 |
| title_sort | 537 star: single-tablet regimen rilpivirine/emtricitabine/tenofovir df has similar efficacy and is well-tolerated compared to efavirenz/emtricitabine/tenofovir df in art-naïve females at week 96 |
| topic | IDWeek 2014 Abstracts |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5782352/ http://dx.doi.org/10.1093/ofid/ofu051.56 |
| work_keys_str_mv | AT creticoscatherine 537starsingletabletregimenrilpivirineemtricitabinetenofovirdfhassimilarefficacyandiswelltoleratedcomparedtoefavirenzemtricitabinetenofovirdfinartnaivefemalesatweek96 AT brinsoncynthia 537starsingletabletregimenrilpivirineemtricitabinetenofovirdfhassimilarefficacyandiswelltoleratedcomparedtoefavirenzemtricitabinetenofovirdfinartnaivefemalesatweek96 AT mcdonaldcheryl 537starsingletabletregimenrilpivirineemtricitabinetenofovirdfhassimilarefficacyandiswelltoleratedcomparedtoefavirenzemtricitabinetenofovirdfinartnaivefemalesatweek96 AT segalmaurersorana 537starsingletabletregimenrilpivirineemtricitabinetenofovirdfhassimilarefficacyandiswelltoleratedcomparedtoefavirenzemtricitabinetenofovirdfinartnaivefemalesatweek96 AT brarindira 537starsingletabletregimenrilpivirineemtricitabinetenofovirdfhassimilarefficacyandiswelltoleratedcomparedtoefavirenzemtricitabinetenofovirdfinartnaivefemalesatweek96 AT wadebarbara 537starsingletabletregimenrilpivirineemtricitabinetenofovirdfhassimilarefficacyandiswelltoleratedcomparedtoefavirenzemtricitabinetenofovirdfinartnaivefemalesatweek96 AT garnerwill 537starsingletabletregimenrilpivirineemtricitabinetenofovirdfhassimilarefficacyandiswelltoleratedcomparedtoefavirenzemtricitabinetenofovirdfinartnaivefemalesatweek96 AT porterdanielle 537starsingletabletregimenrilpivirineemtricitabinetenofovirdfhassimilarefficacyandiswelltoleratedcomparedtoefavirenzemtricitabinetenofovirdfinartnaivefemalesatweek96 AT deoertelshampa 537starsingletabletregimenrilpivirineemtricitabinetenofovirdfhassimilarefficacyandiswelltoleratedcomparedtoefavirenzemtricitabinetenofovirdfinartnaivefemalesatweek96 AT weinbergamy 537starsingletabletregimenrilpivirineemtricitabinetenofovirdfhassimilarefficacyandiswelltoleratedcomparedtoefavirenzemtricitabinetenofovirdfinartnaivefemalesatweek96 AT sparrowtoni 537starsingletabletregimenrilpivirineemtricitabinetenofovirdfhassimilarefficacyandiswelltoleratedcomparedtoefavirenzemtricitabinetenofovirdfinartnaivefemalesatweek96 |